Pfizer says that its pill, used, with an HIV drug, cut the risk of hospitalisation or death by 89% in high-risk adults exposed to COVID-19
This would be the second antiviral pill after Merck’s (which is reported to reduce risks of hospitalisation or death by around 50% with mild or moderate cases of COVID-19) to have
This would be the second antiviral pill after Merck’s (which is reported to reduce risks of hospitalisation or death by around 50% with mild or moderate cases of COVID-19) to have